A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y, Qin SK, Li J, Dai GH, Shen BY, Ying JE, Ba Y, Liang H, Wang XB, Xu Y, Zhou L, Ding KF, Qin YR, Yang SJ, Guan WX, Zheng H, Wang Q, Song H, Zhu YP.
Cheng Y, et al. Among authors: qin yr, qin sk.
J Cancer Res Clin Oncol. 2022 Mar;148(3):673-684. doi: 10.1007/s00432-021-03639-x. Epub 2021 Apr 17.
J Cancer Res Clin Oncol. 2022.
PMID: 33864522